Searchable abstracts of presentations at key conferences in endocrinology

ea0029p877 | Endocrine tumours and neoplasia | ICEECE2012

Management of ectopic Cushing’s syndrome caused by bronchial carcinoid: four case reports

Nemes O. , Molnar T. , Schmidt E. , Doczi T. , Tarjanyi Z. , Ruzsa B. , Bajnok L. , Zambo K. , Mezosi E.

During the evaluation of hypercortisolism, distinction between Cushing’s disease (CD) and ectopic ACTH syndrome (EAS) may be problematic. Detailed medical history, diagnostic procedures and pitfalls associated with EAS of four cases are presented. All the four patients had ectopic Cushing’s syndrome due to typical bronchial carcinoids. Their mean age was 39 years, and the mean time from the presentation of Cushing’s symptomes until diagnosis and definitive cure ...

ea0016s14.4 | Basic highlights | ECE2008

Targeted disruption of Slc2a8 (GLUT8) reduces ATP levels and mitochondrial potential of spermatozoa

Gawlik Verena , Schmidt Stefan , Scheepers Andrea , Wennemuth Gunther , Augustin Robert , Moser Markus , Al-Hasani Hadi , Joost Hans-Georg , Schurmann Annette

GLUT8 is a class 3 sugar transport facilitator, and transports glucose with high affinity (km~2 mM). GLUT8 mRNA is expressed in brain, heart, skeletal muscle, adipose tissue, adrenal gland, liver and at particulary high levels in testis. In testis, the GLUT8 protein is located in an intracellular compartment of spermatocytes, spermatids and mature spermatozoa. GLUT8 contains an N-terminal dileucine sorting signal retaining the transporter in an intracellular compartment. So fa...

ea0016p682 | Thyroid | ECE2008

Smoking as a risk factor for thyroid volume change and incident goiter in a region of normalized iodine supply

Ittermann Till , Schmidt Carsten Oliver , Alte Dietrich , Kramer Axel , Below Harald , John Ulrich , Wallaschofski Henri , Volzke Henry

Objective: The role of smoking in the pathogenesis of thyroid enlargement is currently under debate. The aim of this paper was to investigate the role of smoking on thyroid volume change and incident goiter for different age-strata in a region with normalized iodine supply.Methods: The population-based Study of Health in Pomerania (SHIP) compromised 3300 subjects with complete 5-year examination follow-up. Data from 2484 participants without known thyroi...

ea0016p686 | Thyroid | ECE2008

Is response bias in population studies on iodine supply and thyroid disorders neglectable?

Volzke Henry , Haring Robin , Schmidt Carsten O , Alte Dietrich , Kramer Axel , Hoffmann Wolfgang , John Ulrich , Wallaschofski Henri

Context: Monitoring of iodine fortification programs is required for early recognition of oversupply or ineffective supply with iodine. Potential effects of non-response studies that are aimed at monitoring such programs have not been analysed.Objective: With the present analyses we investigated the potential role of selection bias for studies performed to monitor the iodine supply and prevalence of thyroid disorders.Design: The pr...

ea0014p445 | (1) | ECE2007

Secondary adrenal failure and secondary amenorrhea due to hydromorphone treatment

Müssig Karsten , Knaus-Dittmann Daniele , Schmidt Helmut , Mörike Klaus , Häring Hans-Ulrich

Objective: Opioids are among the most commonly used symptomatic treatments of somatoform pain disorder. Human and animal studies suggest that chronic exposure to opioids suppresses the hypothalamo-pituitary-adrenal (HPA) and the hypothalamic-pituitary-gonadal axis. We report on a rare case of secondary adrenal failure and secondary amenorrhea due to hydromorphone treatment.Case report: A 32-year-old female patient presented with fatigue, weakness, orthos...

ea0056gp63 | Cardiovascular | ECE2018

OCT1 gene variants are associated with cardiovascular characteristics in non-diabetic, prediabetic and diabetic patients

Schweighofer Natascha , Haudum Christoph , Schmidt Albrecht , Colantonio Caterina Raffaela , Mursic Ines , Pieber Thomas R , Obermayer-Pietsch Barbara

Type 2 diabetes (T2DM) patients are at high risk for vascular complications. Some of them have even a higher risk during metformin therapy, as we have recently shown by associations of polymorphisms in the Oct1 gene with a therapy-dependent increased risk of cardiovascular death. In this study, we investigated whether Oct1 gene variants were associated with cardiovascular characteristics such as pulse wave velocity (PWV), echocardiographic parameters and intima/media thickness...

ea0081ep368 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Is MGP an inflammatory marker?

Schweighofer Natascha , Colantonio Caterina , Haudum Christoph W , Hutz Barbara , Kolesnik Ewald , Schmidt Albrecht , Zirlik Andreas , Pieber Thomas R , Verheyen Nicolas , Obermayer-Pietsch Barbara

Matrix-GLA-protein (MGP) was repeatedly associated with inflammation markers during the last decade. It is expressed in leucocytes and is a regulator of immune response. Due to posttranslational modification, there are 4 forms. The form responsible for immunomodulation is still unknown. Since the predicted active form - carboxylated, phosphorylated MGP - is not directly associated with immunomodulation, we aimed to investigate the association of dp-ucMGP (dephosphorylated, unc...

ea0081ep861 | Reproductive and Developmental Endocrinology | ECE2022

Associations of serum AMH levels and hormonal, metabolic and cardiovascular parameters in adult men

Tandl Veronika , Colantonio Caterina , Haudum Christoph W , Hutz Barbara , Kolesnik Ewald , Schmidt Albrecht , Zirlik Andreas , Verheyen Nicolas , Pieber Thomas R , Obermayer-Pietsch Barbara

Background: Anti-Müllerian hormone (AMH) is well known for its association with ovarian follicular count and ovarian reserve in general as well as for its recruitment of primordial follicles in women. With an explicit decrease in menopause, it is mainly used for clinical questions from in-vitro-fertilisation to polycystic ovary syndrome. Interestingly, AMH levels in men are quite high during lifetime, but there is only few data about its relevance and potential effects in...

ea0083erco4 | Endocrine-related Cancer | EYES2022

Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma (ACC)

O Kimpel , P Schindler , L Schmidt-Pennington , B Altieri , F Megerle , R Steenaard , J Pittaway , M Quinkler , K Mai , M. Kroiss , B Polat , M. Fassnacht

Background: The ESE-ENSAT guidelines emphasize the role of local therapies and suggest radiotherapy (RT) as an individualized treatment in patients with advanced ACC. However, the evidence for this recommendation is very low.Objectives: The aim of this study was to retrospectively investigate the efficacy and tolerance of RT in advanced ACC.Methods: We screened all patients in five European reference centers for ACC since 2000 for ...

ea0090p139 | Pituitary and Neuroendocrinology | ECE2023

Patients with acromegaly continue to derive clinical benefit from pasireotide long-acting release (LAR) for up to 12 years of treatment: Follow-up analysis of patients who received pasireotide during the clinical trial programme

Gadelha Monica , Grineva Elena , Miguel Escalante Pulido Jesus , Rollin Guilherme , Leelawattana Rattana , De Block Christophe , Piacentini Andrea , Schmidt Fabian , Pedroncelli Alberto M , Kapoor Nitin

Introduction: Acromegaly is associated with significant morbidity and reduced quality of life. A robust clinical programme (14 trials) established pasireotide as an effective second-generation somatostatin receptor ligand for the treatment of various endocrine conditions, including acromegaly. Patients who completed a previous pasireotide trial and continued to receive clinical benefit, according to the parent study investigator, could continue treatment in the B2412 rollover ...